Atlas Trials

Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines

Clinical trial NCT01953341 · COMPLETED

Trial details

NCT number
NCT01953341
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine
Start date
2013-10-01
Primary completion
2014-09-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.